BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31539394)

  • 1. High specificity and sensitivity of Zika EDIII-based ELISA diagnosis highlighted by a large human reference panel.
    Denis J; Attoumani S; Gravier P; Tenebray B; Garnier A; Briolant S; de Laval F; Chastres V; Grard G; Leparc-Goffart I; Coutard B; Badaut C
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007747. PubMed ID: 31539394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
    Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
    Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.
    Tsai WY; Youn HH; Brites C; Tsai JJ; Tyson J; Pedroso C; Drexler JF; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    Clin Infect Dis; 2017 Nov; 65(11):1829-1836. PubMed ID: 29020159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections.
    Tsai WY; Driesse K; Tsai JJ; Hsieh SC; Sznajder Granat R; Jenkins O; Chang GJ; Wang WK
    Emerg Microbes Infect; 2020 Dec; 9(1):1722-1732. PubMed ID: 32684139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016.
    Steinhagen K; Probst C; Radzimski C; Schmidt-Chanasit J; Emmerich P; van Esbroeck M; Schinkel J; Grobusch MP; Goorhuis A; Warnecke JM; Lattwein E; Komorowski L; Deerberg A; Saschenbrecker S; Stöcker W; Schlumberger W
    Euro Surveill; 2016 Dec; 21(50):. PubMed ID: 28006649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.
    Rockstroh A; Moges B; Barzon L; Sinigaglia A; Palù G; Kumbukgolla W; Schmidt-Chanasit J; Sarno M; Brites C; Moreira-Soto A; Drexler JF; Ferreira OC; Ulbert S
    Emerg Microbes Infect; 2017 Nov; 6(11):e99. PubMed ID: 29116222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
    van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
    J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
    Chao DY; Whitney MT; Davis BS; Medina FA; Munoz JL; Chang GJ
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection.
    Kikuti M; Tauro LB; Moreira PSS; Campos GS; Paploski IAD; Weaver SC; Reis MG; Kitron U; Ribeiro GS
    Virol J; 2018 Jul; 15(1):108. PubMed ID: 30005683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections.
    Furuya AKM; Hunt D; George KS; Dupuis AP; Kramer LD; Shi PY; Wong S
    Clin Sci (Lond); 2019 Apr; 133(7):859-867. PubMed ID: 30902827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NS1-Specific Antibody Response Facilitates the Identification of Children With Dengue and Zika in Hyperendemic Areas.
    Castro-Trujillo S; Segura K; Bolívar-Marín S; Salgado DM; Bosch I; Vega R; Rojas MC; Narváez CF
    Pediatr Infect Dis J; 2024 Feb; 43(2):178-185. PubMed ID: 37963312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population.
    Zaidi MB; Cedillo-Barron L; González Y Almeida ME; Garcia-Cordero J; Campos FD; Namorado-Tonix K; Perez F
    Acta Trop; 2020 Jan; 201():105201. PubMed ID: 31562846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission.
    Medina FA; Vila F; Premkumar L; Lorenzi O; Paz-Bailey G; Alvarado LI; Rivera-Amill V; de Silva A; Waterman S; Muñoz-Jordán J
    Am J Trop Med Hyg; 2021 Dec; 106(2):585-592. PubMed ID: 34929668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research.
    Low SL; Leo YS; Lai YL; Lam S; Tan HH; Wong JCC; Tan LK; Ng LC
    PLoS One; 2021; 16(1):e0244601. PubMed ID: 33497414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus Infections.
    Tyson J; Tsai WY; Tsai JJ; Brites C; Mässgård L; Ha Youn H; Pedroso C; Drexler JF; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30429254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-based assay discriminates Zika virus infection from other flaviviruses.
    Balmaseda A; Stettler K; Medialdea-Carrera R; Collado D; Jin X; Zambrana JV; Jaconi S; Cameroni E; Saborio S; Rovida F; Percivalle E; Ijaz S; Dicks S; Ushiro-Lumb I; Barzon L; Siqueira P; Brown DWG; Baldanti F; Tedder R; Zambon M; de Filippis AMB; Harris E; Corti D
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8384-8389. PubMed ID: 28716913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added value of IgA antibodies against Zika virus non-structural protein 1 in the diagnosis of acute Zika virus infections.
    Warnecke JM; Lattwein E; Saschenbrecker S; Stöcker W; Schlumberger W; Steinhagen K
    J Virol Methods; 2019 May; 267():8-15. PubMed ID: 30779938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing.
    Rojas A; Natrajan MS; Weber J; Cardozo F; Cantero C; Ananta JS; Kost J; Tang M; López S; Bernal C; Guillén Y; Mendoza L; Páez M; Pinsky BA; Waggoner JJ
    Am J Trop Med Hyg; 2021 Mar; 104(5):1729-1733. PubMed ID: 33782214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.